Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
1. Tevogen expects $1 million funding for its AI-driven drug discovery. 2. The funding is part of up to $10 million from KRHP LLC. 3. Tevogen.AI aims to enhance drug development efficiency and accessibility. 4. Company focuses on maximizing shareholder value and patient impact. 5. Forward-looking statements indicate potential growth despite inherent risks.